BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MiraiBio, Inc. (Formerly Hitachi Genetic Systems) Releases MasterPlex(TM) QT Software For The Luminex(R) 200 Platform


12/14/2005 12:33:10 PM

SAN FRANCISCO, Dec. 14 /PRNewswire/ -- At the American Society of Cell Biology Conference, MiraiBio, a division of Hitachi Software Engineering America, Ltd. (HISAL) today announced the release of MasterPlex(TM) QT v2.5 quantitation software for advanced statistical analysis of multiplexed data generated on the Luminex(R) 200 liquid array detection system.

MasterPlex QT software delivers powerful support for large scale inter and intra-plate multiplexed data analysis. Multiple charting capabilities to visualize and compare data include multi-sample charts, 3-dimensional depth charts, and intensity maps. This software package also provides the ability to generate weighted four and five parameter logistics standard curves, dose- response curves, and residual plots.

MasterPlex QT v2.5 enhanced functionality supports gene expression analysis of data produced using commercial assays, including QuantiGene(R) Plex kits (GenoSpectra), automatic outlier detection based on standard deviation within a replicate group, and support for customizable reports. New operational functions such as "hot keys," "copy and paste" as well as enhanced data representation including "replicate graphs with error bars" have been added for easy navigating through large data sets.

As an authorized software partner of Luminex Corporation, MiraiBio has developed robust, flexible and intuitive MasterPlex software products for the analysis of data generated on Luminex(R) 100, 200 and IS multiplex assay platforms. Additional products include MasterPlex CT software for integrated system control and assay data collection and MasterPlex GT genotype and haplotype downstream analysis software. The Luminex 100 and 200 systems are designed for immunoassay, nucleic acid, enzyme function, and receptor-ligand interaction research applications. The Luminex IS system is engineered for in- vitro diagnostic applications in clinical laboratories.

"MiraiBio's relationship with Luminex Corporation, in both an instrument distribution and software development context, has proved to be very fruitful for both companies," commented Masakazu Kuji, General Manager of MiraiBio and Chief Operating Officer of HISAL. "Our continued development of software products for laboratory data management and analysis confirms our commitment to bioinformatics and the life science industry."

MasterPlex QT v2.5 software is available under single-user, multi-user, and concurrent network licensing models. Concurrent network licensing model allows users to install the software on unlimited number of workstations in a local area network. Trial software and application tutorials for MasterPlex QT and additional information on the Luminex 200 system are available on the MiraiBio's website at http://www.miraibio.com.

About MiraiBio

MiraiBio, a division of Hitachi Software Engineering America, Ltd. (HISAL), brings a wealth of experience and dedication to scientific research and the application of instrumentation and software technology to discovery. Providing innovatively integrated system solutions, MiraiBio enables Genomic and Proteomic research in drug discovery, basic research, and forensics. Closely working with life science researchers and technicians, the company's core mission is to deliver solutions that do far more than follow technology trends; that put tomorrow's research tools into the laboratory today. More information about MiraiBio and their products can be found at the company's web site at www.miraibio.com.

About Hitachi Software Engineering America, Ltd.

Hitachi Software Engineering America Ltd. (HISAL) is a wholly owned subsidiary of Hitachi Software Engineering Co. Ltd., one of Japan's premier software and professional service companies. Founded in 1970, Hitachi Software Engineering is a global supplier of solutions-oriented IT products and services, employing over 8,000 people worldwide and enhancing customer businesses through value-added professional services, consulting and support. HISAL was established in 1991 and maintains headquarters in San Francisco and offices in New York and Los Angeles. More information about Hitachi Software Engineering America can be found at the company's web site at www.hitachi-soft.com.

For additional information regarding this announcement, please contact: Tateo Nagai Director of Bioinformatics Phone: 510-337-2000 Email: tnagai@miraibio.com.

MiraiBio

CONTACT: Tateo Nagai, Director of Bioinformatics of MiraiBio,+1-510-337-2000 or tnagai@miraibio.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->